DUBLIN - The U.S. Food and Drug Administration has granted Breakthrough Therapy designation to Alkermes plc’s (NASDAQ:ALKS) experimental drug alixorexton for the treatment of narcolepsy type 1, the ...
DUBLIN, January 06, 2026--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to alixorexton for ...
Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1), ...
Cognitive symptoms associated with narcolepsy type 1 are common, particularly in sustaining attention and processing information. Oveporexton improved attention, memory, and executive function over 8 ...
The MarketWatch News Department was not involved in the creation of this content. -- As the lowest sodium (80mg sodium for 9g dose), once-nightly treatment currently in development, TRN-257 has the ...
As the lowest sodium (80mg sodium for 9g dose), once-nightly treatment currently in development, TRN-257 has the potential to be the new standard of care for adults with narcolepsy (cataplexy or ...
NBC recently debuted a new show called Stumble, a comedy about a former championship-winning junior college cheer coach who’s now leading a team of misfits. Some earlier reviews of the show, which ...
Alkermes has reported another phase 2 win for its narcolepsy drug candidate, succeeding where Takeda failed to maintain its hopes of being first to market in the indication. The trial randomized 93 ...
With plans to pay up to $2.1 billion to acquire its Dublin, Ireland, neighbor Avadel Pharmaceuticals, Alkermes is hoping to gain an immediate growth driver in narcolepsy drug Lumryz. But perhaps more ...
When Katelynn O’Connell takes her lunch break at work, she follows a routine that sets her apart from other employees. Each day at noon, she unfolds a cot in her small office, turns on a white noise ...
Between 2000 and 2021, the top five most mentioned keyword-topics in personality psychology research were “B5 Constructs,” “Emotion,” “Internalizing,” “Health/Well-being,” and “Dark Tetrad.” ...
There is no biological measure for wakefulness. In a narcolepsy clinical trial, a patient lies down in a dark lab while clinicians count the minutes until sleep comes. The average time in four tests ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback